Safety Study of Repeated Doses of Glucagon on Animal Starch in the Liver
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn if giving multiple doses of a hormone called glucagon
can cause a major decrease in liver glycogen (animal starch). Glucagon is currently approved
by the Food and Drug Administration to be given as a large dose to treat severe low blood
sugar. Our group is studying whether glucagon can be given in repeated small doses to prevent
hypoglycemia.
Phase:
N/A
Details
Lead Sponsor:
Legacy Health System
Collaborators:
Juvenile Diabetes Research Foundation Oregon Health and Science University